New shot aims to ease arthritis pain in 30-Patient trial
NCT ID NCT07233655
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental injection called SHR-3045 in 30 adults with moderate to severe rheumatoid arthritis who did not get enough relief from other treatments. The goal is to see if it safely reduces joint pain and swelling. Participants are randomly assigned to receive the drug or a placebo, and neither they nor their doctors know which they get.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People 's Hospital
Beijing, Beijing Municipality, 100044, China